Posts With Tag Clinical-stage Company

Showing 1 - 2 of 2 Posts

Neuphoria Therapeutics Inc. Q4 2024 Financial Report: Challenges and Strategic Outlook

$BNOX

•

Form 10-Q

•

2025-02-14

Last updated: 3 months ago

Neuphoria Therapeutics Inc. Q4 2024 Financial Report: Challenges and Strategic Outlook

Explore Neuphoria Therapeutics Inc.'s Q4 2024 financial performance, highlighting net losses, liquidity issues, and strategic partnerships. A hold recommendation is advised.

Biotechnology Neuropsychiatric Disorders Clinical-stage Company Research and Development Investment Analysis

$SONN

•

Form 10-K

•

2024-12-17

Last updated: 5 months ago

Sonnet BioTherapeutics Q4 2024 Financial Report: Hold Recommendation Amid Challenges

Explore Sonnet BioTherapeutics Q4 2024 financial analysis, highlighting revenue, net loss, cash position, and future funding needs. Key insights for investors and market outlook.

biotechnology cancer therapies financial analysis clinical-stage company collaboration revenue